• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Orchid Pharma Limited — Board Meeting, 14-08-2026: Outcome of Board Meeting

    14-08-2026 | 06:31 pm

    Orchid Pharma's board approved Q1 FY26-27 consolidated financial results. Net Sales hit ₹304.17 Cr, with Profit after tax at ₹3.22 Cr, turning around from a loss. The Dhanuka Labs merger is effective, and global ownership of novel antibiotic EXBLIFEP is secured via Allecra acquisition. #Pharma #Earnings

    No comments yet. Be the first to comment!

    All announcements from Orchid Pharma Limited